The global real estate firm Cushman & Wakefield has announced the acquisition and subsequent sale and leaseback of two cancer treatment centres.
Acting on behalf of GenesisCare, the largest provider of private cancer care services in the UK, Cushman completed the deal to a listed property REIT for an undisclosed sum.
James McArthur, General Manager of UK GenesisCare, said: “GenesisCare launched its first pioneering UK radiation therapy cancer treatment centre in 2009. Today we operate from 14 centres across the UK with Bristol and Chelmsford our latest additions. Throughout our centres our talented specialists provide fast access to ground-breaking treatments, using the very latest equipment ensuring that our patients get the best quality care possible. We are delighted with the outcome and quality of service provided to us by Cushman & Wakefield’s healthcare team.”
Located on Aztec West Business Park, Bristol and Essex Healthcare Park, Great Baddow, Chelmsford, the two state-of-the-art specialist cancer care centres join GenesisCare’s international network of world-leading radiotherapy centres.
James Hanson, Partner and Head of Healthcare Transactions at Cushman & Wakefield, said: “Like most people in the UK, I have personal experience of losing a relative to cancer, and can fully appreciate the importance placed on access to quality cancer treatment facilities and care. We are proud to have advised GenesisCare on this deal and I look forward to further supporting them with their ambitious growth plans here in the UK and globally.”
Cushman and Wakefield have also recently announced 71 promotions across its EMEA business, including five at its Leeds office.